Analysis and data insight
Analysis and data insight RSS Feed RSS

Prostate cancer cells

Meaty Oric? Finding substance in rise of new PC approaches

Aug. 9, 2024
By Randy Osborne

Novartis AG CEO Vas Narasimhan during the company’s July 18 second-quarter earnings call said his firm was “still in the midst of completing” the buyout disclosed in February of Morphosys AG, of Munich, for €2.7 billion (then US$2.9 billion), which brought worldwide rights to pelabresib, the small-molecule BET inhibitor for myelofibrosis.


Read More
Girl in wheelchair

Neuren’s NNV-2591 positive in Angelman syndrome phase II trial

Aug. 9, 2024
By Tamra Sami
Neuren Pharmaceuticals Ltd.’s NNZ-2591 met the primary endpoints in a phase II trial in children with Angelman syndrome, with improvements seen in clinically important aspects of the disease, including communication, behavior, cognition and motor abilities, Neuren CEO Jon Pilcher said during an Aug. 9 conference call.
Read More

As markets tumble, biotech expected to weather economic downturn

Aug. 6, 2024
By Amanda Lanier
Stocks tumbled on Aug. 5, with the Dow Jones Industrial Average falling more than 1,000 points amid a disappointing jobs report released by the U.S. Labor Department on Aug. 2. The BioWorld Stock Index, which tracks approximately 510 U.S. biopharma stocks, was up 17.27% for the year on July 26 before closing Aug. 5 up only 3.47%, representing a significant drop.
Read More